HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Caterina Di Sano Selected Research

Interleukin-17 (Interleukin 17)

1/2016Autocrine Acetylcholine, Induced by IL-17A via NFκB and ERK1/2 Pathway Activation, Promotes MUC5AC and IL-8 Synthesis in Bronchial Epithelial Cells.
1/2016Effect of High, Medium, and Low Molecular Weight Hyaluronan on Inflammation and Oxidative Stress in an In Vitro Model of Human Nasal Epithelial Cells.
12/2015Cigarette smoke affects IL-17A, IL-17F and IL-17 receptor expression in the lung tissue: Ex vivo and in vitro studies.
8/2015IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases.
5/2014Increased levels of Th17 cells are associated with non-neuronal acetylcholine in COPD patients.
1/2013Th17 immunity in children with allergic asthma and rhinitis: a pharmacological approach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Caterina Di Sano Research Topics

Disease

10Inflammation (Inflammations)
03/2019 - 01/2008
8Chronic Obstructive Pulmonary Disease (COPD)
10/2021 - 12/2013
6Neoplasms (Cancer)
06/2022 - 09/2003
5Asthma (Bronchial Asthma)
01/2016 - 01/2012
3Lung Neoplasms (Lung Cancer)
02/2022 - 02/2014
2Adenocarcinoma of Lung
06/2022 - 02/2022
2Adenocarcinoma
06/2022 - 02/2022
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022 - 02/2014
2Melanoma (Melanoma, Malignant)
10/2020 - 11/2019
2Allergic Rhinitis
01/2019 - 08/2015
2Rhinitis
08/2015 - 01/2013
2Infections
08/2003 - 10/2002
2Tuberculosis (Tuberculoses)
12/2002 - 10/2002
1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell)
01/2021
1Insulin Resistance
01/2021
1Lung Diseases (Lung Disease)
04/2020
1Hepatocellular Carcinoma (Hepatoma)
01/2018
1Reinfection
11/2017
1Colonic Neoplasms (Colon Cancer)
08/2017
1Chronic Disease (Chronic Diseases)
11/2016
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2016
1Mucoepidermoid Carcinoma
08/2014
1Leukemia
06/2013
1Malignant Pleural Effusion
01/2011
1Heart Failure
01/2011
1Pleural Effusion (Pleural Effusions)
01/2011
1Shwartzman Phenomenon (Shwartzman Reaction)
03/2007
1Septic Shock (Toxic Shock Syndrome)
03/2007
1Shock
03/2007

Drug/Important Bio-Agent (IBA)

6SmokeIBA
02/2022 - 12/2015
6Interleukin-17 (Interleukin 17)IBA
01/2016 - 01/2013
4Acetylcholine (Acetylcholine Chloride)FDA Link
01/2018 - 12/2013
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2016 - 01/2012
2Interleukin-8 (Interleukin 8)IBA
10/2021 - 01/2013
2Proteins (Proteins, Gene)FDA Link
10/2019 - 12/2002
2Hyaluronic Acid (Hyaluronan)IBA
01/2019 - 01/2016
2GlucocorticoidsIBA
11/2016 - 01/2016
2LipopolysaccharidesIBA
11/2016 - 03/2007
2CytokinesIBA
12/2015 - 03/2007
2olodaterolIBA
05/2014 - 12/2013
2Tiotropium Bromide (Spiriva)FDA Link
05/2014 - 12/2013
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2007 - 08/2003
1LycopeneIBA
06/2022
1PhytochemicalsIBA
06/2022
1oleoresinsIBA
06/2022
1AntioxidantsIBA
06/2022
1Carotenoids (Carotene)IBA
06/2022
1Transcription Factors (Transcription Factor)IBA
01/2021
1Annexin A5IBA
10/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2020
13,4-dihydroxyphenylethanol (hydroxytyrosol)IBA
10/2020
1Olive OilIBA
10/2020
1Halogenated Diphenyl EthersIBA
04/2020
1tetraphenylporphine sulfonate (TPPS)IBA
11/2019
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
11/2019
1di-n-butyltin (dibutyltin)IBA
11/2019
1adhesion receptorIBA
11/2019
1Cyclin D1IBA
11/2019
1tributyltinIBA
11/2019
1Lysine (L-Lysine)FDA Link
10/2019
1Histones (Histone)IBA
10/2019
1VimentinIBA
10/2019
12,2',4,4'-tetrabromodiphenyl etherIBA
03/2019
1LeptinIBA
01/2019
1AdipokinesIBA
01/2019
1Cholinergic Agents (Cholinergics)IBA
01/2018
1MLN2238IBA
01/2018
1Proteasome InhibitorsIBA
01/2018
1ixazomibIBA
01/2018
1oleocanthalIBA
08/2017
1SteroidsIBA
11/2016
1InflammasomesIBA
11/2016
1Fluticasone (Cutivate)FDA LinkGeneric
11/2016
1LipoxinsIBA
01/2016
1lipoxin A4IBA
01/2016
1U 0126 (UO 126)IBA
01/2016
1Biological ProductsIBA
01/2016
1Leukotriene B4IBA
01/2016
1Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
01/2016
1Mucin 5ACIBA
08/2014
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
08/2014
1Interleukin-22 (IL-22)IBA
05/2014
1Caspase 3 (Caspase-3)IBA
02/2014
1Caspase 8 (Caspase-8)IBA
02/2014
1Fas Ligand Protein (Fas Ligand)IBA
02/2014
1GemcitabineFDA Link
02/2014
1Pharmaceutical PreparationsIBA
12/2013
1Bronchodilator Agents (Bronchodilators)IBA
12/2013
1Muscarinic AntagonistsIBA
12/2013
13-nitrotyrosineIBA
12/2013
1ChlorineIBA
06/2013
1Formoterol Fumarate (Oxis)FDA Link
01/2013
1Budesonide (Pulmicort)FDA LinkGeneric
01/2013
1PerforinIBA
01/2011
1Fibril-Associated Collagens (FACIT Collagen)IBA
01/2008
1Interleukin-10 (Interleukin 10)IBA
03/2007
1Interleukin-4 (Interleukin 4)IBA
03/2007
1LigandsIBA
03/2007

Therapy/Procedure

1Therapeutics
01/2016
1Drug Therapy (Chemotherapy)
02/2014